IFNL4 Genotype Is Associated With Virologic Relapse After 8-Week Treatment With Sofosbuvir, Velpatasvir, and Voxilaprevir
Date
2017Journal
GastroenterologyPublisher
W.B. SaundersType
Article
Metadata
Show full item recordKeyword
HepacivirusCarbamates--administration & dosage
Hepatitis C, Chronic--genetics
Heterocyclic Compounds, 4 or More Rings--administration & dosage*
Interleukins--analysis
Macrocyclic Compounds--administration & dosage
Sofosbuvir--administration & dosage
Sulfonamides--administration & dosage
Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85035029912&doi=10.1053%2fj.gastro.2017.06.069&partnerID=40&md5=2498d61cc0b9f11975f8c572161c1aac; http://hdl.handle.net/10713/11082ae974a485f413a2113503eed53cd6c53
10.1053/j.gastro.2017.06.069